155 related articles for article (PubMed ID: 15618625)
21. Determination of p-glycoprotein ATPase activity using luciferase.
Matsunaga T; Kose E; Yasuda S; Ise H; Ikeda U; Ohmori S
Biol Pharm Bull; 2006 Mar; 29(3):560-4. PubMed ID: 16508168
[TBL] [Abstract][Full Text] [Related]
22. Atorvastatin coadministration may increase digoxin concentrations by inhibition of intestinal P-glycoprotein-mediated secretion.
Boyd RA; Stern RH; Stewart BH; Wu X; Reyner EL; Zegarac EA; Randinitis EJ; Whitfield L
J Clin Pharmacol; 2000 Jan; 40(1):91-8. PubMed ID: 10631627
[TBL] [Abstract][Full Text] [Related]
23. Intestinal P glycoprotein acts as a natural defense mechanism against Listeria monocytogenes.
Neudeck BL; Loeb JM; Faith NG; Czuprynski CJ
Infect Immun; 2004 Jul; 72(7):3849-54. PubMed ID: 15213126
[TBL] [Abstract][Full Text] [Related]
24. Sphingoid Base-Upregulated Caspase-14 Expression Involves MAPK.
Nagahara Y; Kawakami K; Sikandan A; Yagi D; Nishikawa R; Shinomiya T
Biol Pharm Bull; 2018; 41(5):743-748. PubMed ID: 29709911
[TBL] [Abstract][Full Text] [Related]
25. Interaction of pristinamycin IA with P-glycoprotein in human intestinal epithelial cells.
Phung-Ba V; Warnery A; Scherman D; Wils P
Eur J Pharmacol; 1995 Jan; 288(2):187-92. PubMed ID: 7720780
[TBL] [Abstract][Full Text] [Related]
26. pH-dependent bidirectional transport of weakly basic drugs across Caco-2 monolayers: implications for drug-drug interactions.
Neuhoff S; Ungell AL; Zamora I; Artursson P
Pharm Res; 2003 Aug; 20(8):1141-8. PubMed ID: 12948010
[TBL] [Abstract][Full Text] [Related]
27. Validation and application of Caco-2 assays for the in vitro evaluation of development candidate drugs as substrates or inhibitors of P-glycoprotein to support regulatory submissions.
Elsby R; Surry DD; Smith VN; Gray AJ
Xenobiotica; 2008 Jul; 38(7-8):1140-64. PubMed ID: 18668443
[TBL] [Abstract][Full Text] [Related]
28. Formation of endogenous free sphingoid bases in cells induced by changing medium conditions.
Lavie Y; Blusztajn JK; Liscovitch M
Biochim Biophys Acta; 1994 Feb; 1220(3):323-8. PubMed ID: 8305506
[TBL] [Abstract][Full Text] [Related]
29. Kinetic profiling of P-glycoprotein-mediated drug efflux in rat and human intestinal epithelia.
Stephens RH; O'Neill CA; Warhurst A; Carlson GL; Rowland M; Warhurst G
J Pharmacol Exp Ther; 2001 Feb; 296(2):584-91. PubMed ID: 11160647
[TBL] [Abstract][Full Text] [Related]
30. Effects of nonsteroidal anti-inflammatory drugs on the expression and function of P-glycoprotein/MDR1 in Caco-2 cells.
Takara K; Hayashi R; Kokufu M; Yamamoto K; Kitada N; Ohnishi N; Yokoyama T
Drug Chem Toxicol; 2009; 32(4):332-7. PubMed ID: 19793025
[TBL] [Abstract][Full Text] [Related]
31. Effect of Stereochemical Configuration on the Transport and Metabolism of Catechins from Green Tea across Caco-2 Monolayers.
Ai Z; Liu S; Qu F; Zhang H; Chen Y; Ni D
Molecules; 2019 Mar; 24(6):. PubMed ID: 30917581
[TBL] [Abstract][Full Text] [Related]
32. Effect of Oregon grape root extracts on P-glycoprotein mediated transport in
Fan Y; Zhou Z; Zhang L
J Pharm Pharm Sci; 2023; 26():11927. PubMed ID: 38304488
[No Abstract] [Full Text] [Related]
33. Delineating the contribution of secretory transporters in the efflux of etoposide using Madin-Darby canine kidney (MDCK) cells overexpressing P-glycoprotein (Pgp), multidrug resistance-associated protein (MRP1), and canalicular multispecific organic anion transporter (cMOAT).
Guo A; Marinaro W; Hu P; Sinko PJ
Drug Metab Dispos; 2002 Apr; 30(4):457-63. PubMed ID: 11901101
[TBL] [Abstract][Full Text] [Related]
34. Influence of drugs and nutrients on transporter gene expression levels in Caco-2 and LS180 intestinal epithelial cell lines.
Li Q; Sai Y; Kato Y; Tamai I; Tsuji A
Pharm Res; 2003 Aug; 20(8):1119-24. PubMed ID: 12948007
[TBL] [Abstract][Full Text] [Related]
35. Intestinal transport of irinotecan in Caco-2 cells and MDCK II cells overexpressing efflux transporters Pgp, cMOAT, and MRP1.
Luo FR; Paranjpe PV; Guo A; Rubin E; Sinko P
Drug Metab Dispos; 2002 Jul; 30(7):763-70. PubMed ID: 12065434
[TBL] [Abstract][Full Text] [Related]
36. Nucleobase- and p-glycoprotein-mediated transport of AG337 in a Caco-2 cell culture model.
Hu M; Chen J
Mol Pharm; 2004; 1(3):194-200. PubMed ID: 15981922
[TBL] [Abstract][Full Text] [Related]
37. Selective inhibition of human cytochrome P450 3A4 by N-[2(R)-hydroxy-1(S)-indanyl]-5-[2(S)-(1, 1-dimethylethylaminocarbonyl)-4-[(furo[2, 3-b]pyridin-5-yl)methyl]piperazin-1-yl]-4(S)-hydroxy-2(R)-phenylmethy lpentanamide and P-glycoprotein by valspodar in gene transfectant systems.
Kawahara I; Kato Y; Suzuki H; Achira M; Ito K; Crespi CL; Sugiyama Y
Drug Metab Dispos; 2000 Oct; 28(10):1238-43. PubMed ID: 10997946
[TBL] [Abstract][Full Text] [Related]
38. Sphingolipid perturbations as mechanisms for fumonisin carcinogenesis.
Riley RT; Enongene E; Voss KA; Norred WP; Meredith FI; Sharma RP; Spitsbergen J; Williams DE; Carlson DB; Merrill AH
Environ Health Perspect; 2001 May; 109 Suppl 2(Suppl 2):301-8. PubMed ID: 11359699
[TBL] [Abstract][Full Text] [Related]
39. Transport of 5,5-diphenylbarbituric acid and its precursors and their effect on P-gp, MRP2 and CYP3A4 in Caco-2 and LS180 cells.
Fan J; Maeng HJ; Du Y; Kwan D; Pang KS
Eur J Pharm Sci; 2011 Jan; 42(1-2):19-29. PubMed ID: 20955791
[TBL] [Abstract][Full Text] [Related]
40. Transport of the cooked-food mutagen 2-amino-1-methyl-6-phenylimidazo-[4,5-b]pyridine (PhIP) across the human intestinal Caco-2 cell monolayer: role of efflux pumps.
Walle UK; Walle T
Carcinogenesis; 1999 Nov; 20(11):2153-7. PubMed ID: 10545419
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
